Lara MS, Riess JW, Goldman JW, Jiang F, et al. Current Trial Report: A Multicenter Phase I/Ib study of Capmatinib Plus Trametinib in Patients With Metastatic Nonsmall Cell Lung Center Harboring MET Exon 14 Skipping Mutations and Other MET-Alterations. Clin Lung Cancer 2024;25:732-737.
PMID: 39089913